Skip to main content
Premium Trial:

Request an Annual Quote

Flow Cytometry Startup BennuBio Secures $5M in Series B Funding Round

NEW YORK – Flow cytometry startup BennuBio has closed on $5 million of a $7 million Series B financing round, which it plans to use to expand commercial efforts, accelerate development of new features for its initial product, and develop additional complementary products.

The funding round was led by new investor Co-Win Ventures, with additional investment by existing investors Tramway Partners, Cottonwood Technology Fund, and Sun Mountain Capital. Xin Huang, managing partner at Co-Win Ventures, will also join BennuBio's board of directors.

Albuquerque, New Mexico-based BennuBio is developing its VeloCyt flow cytometer platform, which uses acoustic technology to measures cellular properties, model tissue systems, small organisms, and other particles. The firm believes that VeloCyt's properties will allow rare cell detection for numerous diseases and rapid discovery of new pharmaceuticals for cancer treatment and other diseases. 

In addition to VeloCyt, BennuBio said that it is developing products for rare cell sorting and 3D tissue model generation for disease research.

"We believe BennuBio's innovative cell and particle analysis platform will play an important role in high-growth research markets throughout the life sciences and potential clinical applications," Huang said in a statement.

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.